Return to homepagePandemic Pact

Enterics, Diagnostics, Genomics & Epidemiology

Grant number: INV-082927

Grant search

Key facts

  • Disease

    Shigellosis

  • Start & end year

    2024
    2028

  • Known Financial Commitments (USD)

    $1,147,089

  • Funder

    Gates Foundation

  • Research Location

    France

  • Lead Research Institution

    Pasteur Institute

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Vaccine logistics and supply chains and distribution strategies

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

to test the stability of the Institut Pasteur-quadrivalent Shigella vaccine (IP-QSV), a promising quadrivalent candidate vaccine developed to prevent shigellosis in children from low- and middle-income countries